Loading...

Abbott Laboratories

ABL.DEXETRA
Healthcare
Medical - Devices
74.12
-1.30(-1.72%)
German Market opens in 15h 17m

ABL.DE News Today: Stay Updated with the Latest Abbott Laboratories News in Real Time

Find ABL.DE news now at Meyka AI. Stay informed with the latest Abbott Laboratories stocks updates, including price news, market analysis, and expert insights.

DXCM DexCom Earnings Beat: Q1 2026 EPS Crushes Estimates
📅 4 days ago

DXCM DexCom Earnings Beat: Q1 2026 EPS Crushes Estimates

DexCom Q1 2026 earnings beat: EPS $0.56 vs $0.47 estimate (+19%), revenue $1.19B vs $1.17B (+1.5%)

Read more
ORCHIDPHAR.BO Stock Drops 2.53% on May 1 with 24,701 Volume Spike
📅 5 days ago

ORCHIDPHAR.BO Stock Drops 2.53% on May 1 with 24,701 Volume Spike

ORCHIDPHAR.BO stock fell 2.53% to INR 741.55 on BSE with volume spike to 24,701 shares. Pharma analysis inside.

Read more
SOFT.BR stock surges 18% on April 30, 2026 as Softimat gains momentum
📅 6 days ago

SOFT.BR stock surges 18% on April 30, 2026 as Softimat gains momentum

SOFT.BR stock jumps 18% to €0.85 on EURONEXT. Softimat S.A. real estate stock shows strong intraday gains with 1,502 shares traded.

Read more
NOVATEOR.BO Stock Bounces 5% in Pre-Market on April 30
📅 6 days ago

NOVATEOR.BO Stock Bounces 5% in Pre-Market on April 30

NOVATEOR.BO stock drops 4.99% to INR 31.21 on BSE. Oversold bounce signals potential recovery for Novateor Research Laboratories.

Read more
GV.PA Stock Surges 5.88% on EURONEXT as Genomic Vision Gains Traction
📅 7 days ago

GV.PA Stock Surges 5.88% on EURONEXT as Genomic Vision Gains Traction

GV.PA stock rises 5.88% to €0.0018 on EURONEXT. Genomic Vision SA shows trading momentum despite long-term headwinds in molecular diagnostics.

Read more
DXCM Earnings Preview: DexCom Q2 2026 on April 30
📅 7 days ago

DXCM Earnings Preview: DexCom Q2 2026 on April 30

DexCom earnings preview: $0.47 EPS and $1.17B revenue expected April 30. Analyst consensus, historical trends, and key metrics.

Read more
IDXX Maintained at Neutral by UBS, Price Target Cut to $640
📅 7 days ago

IDXX Maintained at Neutral by UBS, Price Target Cut to $640

UBS maintained IDXX at Neutral rating, lowering price target to $640 from $730 on April 28, 2026.

Read more
VINEETLAB.NS stock falls 14.16% on NSE, 29 Apr 2026
📅 8 days ago

VINEETLAB.NS stock falls 14.16% on NSE, 29 Apr 2026

VINEETLAB.NS stock crashes 14.16% to INR 36.44 on NSE pre-market. Negative earnings and weak fundamentals drive losses.

Read more
Japan’s Ministry of Education April 29: Quantum Research Initiative
📅 8 days ago

Japan’s Ministry of Education April 29: Quantum Research Initiative

Japan’s Ministry of Education advances quantum research through Osaka University collaboration, investing in quantum computing and networks.

Read more

ABL.DE News FAQ